Morcellator Lawsuit News: FDA Schedules Advisory Panel Meeting to Review Uterine Cancer Risks Associ

The Firm is evaluating morcellator lawsuits on behalf of women who underwent uterine surgery with a power morcellator and allegedly experienced the spread of uterine sarcoma and other cancers due to the device. New York New York (PRWEB) June 10, 2014 As morcellator lawsuits (http://www.gynecaremorcellatorlawsuit.com/) continue to mount in U.S. courts, Bernstein Liebhard LLP notes that the U.S. Food & Drug Administration (FDA) has officially scheduled an advisory panel meeting to review the uterine cancer risks associated with the use of power morcellators in minimally-invasive gynecolo
Contributor
PR Web
PR Web
Lanham, Maryland
Law Marketing
1.800.345.5572
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Download

Related Documents in PR Web
MCLE Sales

Categories